Talaris Therapeutics to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference

Rhea-AI Summary

BOSTON and LOUISVILLE, Ky., Jan. 4, 2022 – Talaris Therapeutics (Nasdaq: TALS), a late-clinical stage cell therapy company, announced that CEO Scott Requadt will present at the H.C. Wainwright BioConnect 2022 Virtual Conference from January 10-13, 2022. The pre-recorded presentation will be available starting at 7:00 AM ET on January 10 on Talaris' website, where it will remain archived for 90 days. Talaris focuses on developing therapies aimed at revolutionizing treatment for solid organ transplantation and severe immune and blood disorders.

BOSTON and LOUISVILLE, Ky., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that Scott Requadt, Chief Executive Officer of Talaris, will present at the H.C. Wainwright BioConnect 2022 Virtual Conference being held January 10-13, 2022.

A webcast of the pre-recorded presentation will be made available the morning of the conference starting at 7:00 AM ET on Monday, January 10^th, and can be accessed by visiting the investors section of the Talaris website at www.talaristx.com. After the live webcast, the event will remain archived on the Talaris website for 90 days.

About Talaris Therapeutics
Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders. Talaris maintains corporate offices in Boston, MA, its cell processing facility in Louisville, KY, and additional research operations in Houston, TX.

Media Contact
Lisa Raffensperger
Ten Bridge Communications
lisa@tenbridgecommunications.com
(617) 903-8783

Investor Contact
Chris Brinzey
Westwicke, an ICR Company
chris.brinzey@westwicke.com
(339) 970-2843

FAQ

When will Talaris Therapeutics present at the H.C. Wainwright BioConnect 2022 Conference?

Talaris Therapeutics will present at the H.C. Wainwright BioConnect 2022 Conference from January 10-13, 2022.

What time will the Talaris presentation be available during the conference?

The pre-recorded presentation by Talaris will be available starting at 7:00 AM ET on January 10, 2022.

Where can I watch the Talaris Therapeutics presentation?

You can watch the Talaris presentation by visiting the investors section of their website at www.talaristx.com.

How long will the Talaris presentation be available for viewing?

The Talaris presentation will be archived on their website for 90 days after the conference.

What is the focus of Talaris Therapeutics?

Talaris Therapeutics focuses on developing cell therapies that aim to transform the standard of care for solid organ transplantation and severe immune and blood disorders.